Retraction:Maternal serum amyloid A level as a novel marker of primary unexplained recurrent early pregnancy loss(Int J Gynecol Obstet, (2017), 136, (298–303), 10.1002/ijgo.12076);Maternal serum amyloid A level as a novel marker of primary unexplained recurrent early pregnancy loss

International Journal of Gynecology and Obstetrics

Volumn 136, Issue 3, 2017, Pages 298-303

  Ibrahim, Moustafa I ^a   Ramy, Ahmed R ^a   Abdelhamid, Ahmed S ^a   Ellaithy, Mohamed I ^a   Omar, Amna ^a   Harara, Rany M ^a   Fathy, Hayam ^a   Abolouz, Ashraf S ^b  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b 6th of October City   (Egypt)

Author keywords

Primary unexplained recurrent early pregnancy loss; Recurrent spontaneous abortion; Serum amyloid A; Syncytialization; Trophoblastic invasion

Indexed keywords

BIOLOGICAL MARKER; SERUM AMYLOID A;

ADULT; ARTICLE; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL SERUM; PARITY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECURRENT ABORTION; SPONTANEOUS ABORTION; TROPHOBLAST; BLOOD; CASE CONTROL STUDY; EGYPT; EMBRYO DEATH; MULTIVARIATE ANALYSIS; PREGNANCY; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL MODEL; YOUNG ADULT;

ABORTION, HABITUAL; ADULT; BIOMARKERS; CASE-CONTROL STUDIES; EGYPT; EMBRYO LOSS; FEMALE; HUMANS; LOGISTIC MODELS; MATERNAL AGE; MULTIVARIATE ANALYSIS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PROSPECTIVE STUDIES; ROC CURVE; SERUM AMYLOID A PROTEIN; YOUNG ADULT;

EID: 85020374389     PISSN: 00207292     EISSN: 18793479     Source Type: Journal    
DOI: 10.1002/ijgo.15007     Document Type: Erratum

References (24)

1. Saravelos SH, Regan L. Unexplained recurrent pregnancy loss. Obstet Gynecol Clin North Am. 2014;41:157–166.
2. Kolte AM, Bernardi LA, Christiansen OB, et al. Terminology for pregnancy loss prior to viability: A consensus statement from the ESHRE early pregnancy special interest group. Hum Reprod. 2015;30:495–498.
3. Sandri S, Urban BA, Fernandes I, et al. Serum amyloid A in the placenta and its role in trophoblast invasion. PLoS ONE. 2014;9:e90881.
4. Knebel FH, Albuquerque RC, Massaro RR, Maria-Engler SS, Campa A. Dual effect of serum amyloid A on the invasiveness of glioma cells. Mediators Inflamm. 2013;2013:509089.
5. Urieli-Shoval S, Linke RP, Matzner Y. Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states. Curr Opin Hematol. 2000;7:64–69.
6. Kovacevic A, Hammer A, Sundl M, et al. Expression of serum amyloid A transcripts in human trophoblast and fetal-derived trophoblast-like choriocarcinoma cells. FEBS Lett. 2006;580:161–167.
7. Eklund KK, Niemi K, Kovanen PT. Immune functions of serum amyloid A. Crit Rev Immunol. 2012;32:335–348.
8. Borbely AU, Sandri S, Fernandes IR, et al. The term basal plate of the human placenta as a source of functional extravillous trophoblast cells. Reprod Biol Endocrinol. 2014;12:7.
9. Ibrahim MI, Harb HM, Ellaithy MI, Elkabarity RH, Abdelgwad MH. First trimester assessment of pentraxin-3 levels in women with primary unexplained recurrent pregnancy loss. Eur J Obstet Gynecol Reprod Biol. 2012;165:37–41.
10. Griebel CP, Halvorsen J, Golemon TB, Day AA. Management of spontaneous abortion. Am Fam Physician. 2005;72:1243–1250.
11. Benaitreau D, Dos SE, Leneveu MC, De MP, Pecquery R, Dieudonne MN. Adiponectin promotes syncytialisation of BeWo cell line and primary trophoblast cells. Reprod Biol Endocrinol. 2010;8:128.
12. Leisser C, Saleh L, Haider S, Husslein H, Sonderegger S, Knofler M. Tumour necrosis factor-alpha impairs chorionic gonadotrophin beta-subunit expression and cell fusion of human villous cytotrophoblast. Mol Hum Reprod. 2006;12:601–609.
13. Bauer S, Pollheimer J, Hartmann J, Husslein P, Aplin JD, Knofler M. Tumor necrosis factor-alpha inhibits trophoblast migration through elevation of plasminogen activator inhibitor-1 in first-trimester villous explant cultures. J Clin Endocrinol Metab. 2004;89:812–822.
14. Xu B, Nakhla S, Makris A, Hennessy A. TNF-alpha inhibits trophoblast integration into endothelial cellular networks. Placenta. 2011;32:241–246.
15. Sharma S, Norris WE, Kalkunte S. Beyond the threshold: An etiological bridge between hypoxia and immunity in preeclampsia. J Reprod Immunol. 2010;85:112–116.
16. Almasry SM, Eldomiaty MA, Elfayomy AK, Habib FA. Expression pattern of tumor necrosis factor alpha in placentae of idiopathic fetal growth restriction. J Mol Histol. 2012;43:253–261.
17. Engin-Ustun Y, Ustun Y, Karabulut AB, Ozkaplan E, Meydanli MM, Kafkasli A. Serum amyloid A levels are increased in pre-eclampsia. Gynecol Obstet Invest. 2007;64:117–120.
18. Kishimoto T, Akira S, Narazaki M, Taga T. Interleukin-6 family of cytokines and gp130. Blood. 1995;86:1243–1254.
19. Naka T, Nishimoto N, Kishimoto T. The paradigm of IL-6: From basic science to medicine. Arthritis Res. 2002;4(Suppl.3):S233–S242.
20. Kishimoto T. Interleukin-6: Discovery of a pleiotropic cytokine. Arthritis Res Ther. 2006;8(Suppl.2):S2.
21. Nishimoto N, Kishimoto T, Yoshizaki K. Anti-interleukin 6 receptor antibody treatment in rheumatic disease. Ann Rheum Dis. 2000;59(Suppl.1):i21–i27.
22. Mihara M, Shiina M, Nishimoto N, Yoshizaki K, Kishimoto T, Akamatsu K. Anti-interleukin 6 receptor antibody inhibits murine AA-amyloidosis. J Rheumatol. 2004;31:1132–1138.
23. Arruvito L, Billordo A, Capucchio M, Prada ME, Fainboim L. IL-6 trans-signaling and the frequency of CD4+FOXP3+ cells in women with reproductive failure. J Reprod Immunol. 2009;82:158–165.
24. Vitoratos N, Papadias C, Economou E, Makrakis E, Panoulis C, Creatsas G. Elevated circulating IL-1beta and TNF-alpha, and unaltered IL-6 in first-trimester pregnancies complicated by threatened abortion with an adverse outcome. Mediators Inflamm. 2006;2006:30485.